RSU-based sale of 2,460 Codexis (NASDAQ: CDXS) shares

Rhea-AI Filing Summary

Codexis associated holder filed a notice of proposed sale of 2,460 shares of Codexis common stock. The shares are expected to be sold through Morgan Stanley Smith Barney on or about February 6, 2026 on the NASDAQ.

The filing lists an aggregate market value of 3124.20 for the shares to be sold and notes that 90,324,383 shares of common stock were outstanding. The 2,460 shares were acquired on February 6, 2026 via RSU vesting and settlement as consideration for services rendered.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney Executive Financial Services 1 New York Plaza, 8th Floor New York NY 10004	2460	3124.20	90324383	02/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/06/2026	RSU vesting and settlement	Issuer			2460	02/06/2026	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for Codexis (CDXS) disclose?

The Form 144 discloses a planned sale of 2,460 Codexis common shares. The seller intends to sell through Morgan Stanley Smith Barney, with an aggregate market value of 3124.20, on or about February 6, 2026, on the NASDAQ exchange.

How many Codexis (CDXS) shares are planned to be sold and on which exchange?

The notice covers a proposed sale of 2,460 Codexis common shares. The shares are expected to be sold on the NASDAQ exchange through Morgan Stanley Smith Barney, with an approximate sale date of February 6, 2026, according to the filing.

How were the Codexis (CDXS) shares in this Form 144 acquired?

The 2,460 Codexis shares were acquired via RSU vesting and settlement on February 6, 2026. The filing states the consideration was “services rendered,” indicating the shares came from equity compensation rather than a cash purchase from a third party.

What is the aggregate market value of Codexis (CDXS) shares in this planned sale?

The filing reports an aggregate market value of 3124.20 for the 2,460 Codexis common shares to be sold. This value is tied to the planned NASDAQ sale through Morgan Stanley Smith Barney around February 6, 2026.

How many Codexis (CDXS) shares were outstanding as referenced in the Form 144?

The Form 144 notes that 90,324,383 Codexis common shares were outstanding. This figure provides context for the planned sale of 2,460 shares, showing the proposed transaction is small relative to the total outstanding share count.

What representations does the seller make in the Codexis (CDXS) Form 144?

The seller represents that they do not know any material adverse, non-public information about Codexis’ current or prospective operations. The form also warns that intentional misstatements or omissions may constitute federal criminal violations under 18 U.S.C. 1001.